Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kate Haviland


  • Chief Operating Officer at Blueprint Medicines Corp (BPMC), 2019-08-21
  • Director at Fulcrum Therapeutics Inc. (FULC), 2019-07-18
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BPMC $85.00 95 Officer 15,865 2019-08-19 Filing
BPMC $95.03 349 Officer 15,865 2019-07-16 Filing
BPMC $95.60 1,222 Officer 16,214 2019-07-16 Filing
BPMC $94.44 2,370 Officer 5,874 2019-06-17 Filing
BPMC $95.53 2,549 Officer 8,244 2019-06-17 Filing